Physician profile
Lacinda M Rishel
NPI 1619286739
$271.62
in general payments reported to CMS, 2019-2025
11 companies · $62.48 in 2025
The $62.48 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $86.48 · 2022: $46.91 · 2023: $45.25 · 2024: $30.50 · 2025: $62.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $138.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $138.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $50.07 | 2021-2024 | Physio-Stim |
| Pacira Therapeutics, INC. | $39.95 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $34.29 | 2022-2025 | Exparel |
| Ferring Pharmaceuticals INC. | $30.79 | 2023 | Euflexxa |
| Davol INC. | $24.99 | 2025 | Arista |
| Solventum Corporation | $18.62 | 2025 | Prevena, V.A.C. Veraflo, V.A.C.Ulta |
| Zimmer Biomet Holdings, INC. | $17.41 | 2022 | |
| Spr Therapeutics, INC | $16.02 | 2024 | Sprint Pns System |
| Horizon Therapeutics Plc | $14.08 | 2022 | |
| Endo Pharmaceuticals INC. | $13.09 | 2021 | |
| Depuy Synthes Sales INC. | $12.31 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lacinda Rishel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.